Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.
about
Zolpidem prescribing practices before and after Food and Drug Administration required product labeling changes.Is there a clinically relevant interaction between clarithromycin and statins not metabolized by cytochrome P450 3A4?Gemfibrozil in Combination with Statins-Is It Really Contraindicated?Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition.
P2860
Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Simvastatin prescribing patter ...... ge healthcare claims database.
@en
Simvastatin prescribing patter ...... ge healthcare claims database.
@nl
type
label
Simvastatin prescribing patter ...... ge healthcare claims database.
@en
Simvastatin prescribing patter ...... ge healthcare claims database.
@nl
prefLabel
Simvastatin prescribing patter ...... ge healthcare claims database.
@en
Simvastatin prescribing patter ...... ge healthcare claims database.
@nl
P2093
P2860
P1476
Simvastatin prescribing patter ...... ge healthcare claims database.
@en
P2093
Kavita Nair
Rhianna M Tuchscherer
Vahram Ghushchyan
P2860
P2888
P356
10.1007/S40256-014-0096-X
P577
2015-02-01T00:00:00Z